{"disease":{"id":"kidney-tumor","name":"kidney tumor"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00898365","title":"Study of Kidney Tumors in Younger Patients","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":8000,"lead_sponsor_name":"Children's Oncology Group","has_results":false},{"nct_id":"NCT06401330","title":"A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":1656,"lead_sponsor_name":"Children's Oncology Group","has_results":false},{"nct_id":"NCT00352534","title":"Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":808,"lead_sponsor_name":"Children's Oncology Group","has_results":true},{"nct_id":"NCT00379340","title":"Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":395,"lead_sponsor_name":"Children's Oncology Group","has_results":true},{"nct_id":"NCT06056505","title":"Virtual Interactive 3D Modelling to Improve Outcomes in Robotic-Assisted Partial Nephrectomy","phase":"NA","overall_status":"RECRUITING","enrollment_count":370,"lead_sponsor_name":"University of Leipzig","has_results":false},{"nct_id":"NCT05404685","title":"Partial Nephrectomy in Low Pressure","phase":"NA","overall_status":"COMPLETED","enrollment_count":280,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT03819569","title":"GRADE-SRM: Genomic Risk Assessment and Decisional Evaluation for Small Renal Masses","phase":"NA","overall_status":"COMPLETED","enrollment_count":265,"lead_sponsor_name":"UNC Lineberger Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT04322318","title":"A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":256,"lead_sponsor_name":"Children's Oncology Group","has_results":false},{"nct_id":"NCT00945009","title":"Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":249,"lead_sponsor_name":"Children's Oncology Group","has_results":true},{"nct_id":"NCT07480044","title":"A Phase II Clinical Two-Stage Study of Transcranial Magnetic Stimulation in Preventing Postoperative Delirium in Elderly Patients After Urological Surgery","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":220,"lead_sponsor_name":"Zhejiang University","has_results":false},{"nct_id":"NCT07062952","title":"Kidney-protective Intervention With Salt Substitute After Kidney Tumor Surgery","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Jinling Hospital, China","has_results":false},{"nct_id":"NCT02867592","title":"Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":109,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT07053462","title":"CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC","has_results":false},{"nct_id":"NCT05015179","title":"Mixed Reality Technology in Laparoscopic Partial Nephrectomy","phase":"NA","overall_status":"COMPLETED","enrollment_count":47,"lead_sponsor_name":"St. Petersburg State Pavlov Medical University","has_results":false},{"nct_id":"NCT00638898","title":"Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT03526250","title":"Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":23,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT03213704","title":"Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":9,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT04284774","title":"Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":5,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT00960063","title":"A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006)","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":4,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true}],"total":19},"guidelines":[],"source":"Drug Landscape verified database"}